Nanobiotechnology for Hemoglobin-based Blood Substitutes

Overview

Journal Crit Care Clin

Specialty Critical Care

Date 2009 Apr 4

PMID 19341914

Citations 12

Authors

T M S Chang

Affiliations

Soon will be listed here.

Abstract

Nanobiotechnology is the assembling of biological molecules into nanodimension complexes. This has been used for the preparation of polyhemoglobin formed by the assembling of hemoglobin molecules into a soluble nanodimension complex. New generations of this approach include the nanobiotechnological assembly of hemoglobin, catalase, and superoxide dismutase into a soluble nanodimension complex. This acts as an oxygen carrier and an antioxidant for those conditions with potential for ischemiareperfusion injuries. Another recent novel approach is the assembling of hemoglobin and fibrinogen into a soluble nanodimension polyhemoglobin-fibrinogen complex that acts as an oxygen carrier with platelet-like activity. This is potentially useful in cases of extensive blood loss requiring massive replacement using blood substitutes, resulting in the need for the replacement of platelets and clotting factors. A further step is the preparation of nanodimension artificial red blood cells that contain hemoglobin and all the enzymes present in red blood cells.

Citing Articles

Red Blood Cell Substitutes: Liposome Encapsulated Hemoglobin and Magnetite Nanoparticle Conjugates as Oxygen Carriers.

Hafeez S, Zaidi N Int J Mol Sci. 2023; 24(2).

PMID: 36675142 PMC: 9862797. DOI: 10.3390/ijms24021618.

Glutaraldehyde-Polymerized Hemerythrin: Evaluation of Performance as an Oxygen Carrier in Hemorrhage Models.

Stoica A, Toma V, Roman I, Sevastre B, Scurtu F, Silaghi-Dumitrescu R Bioinorg Chem Appl. 2023; 2022:2209101.

PMID: 36620348 PMC: 9822766. DOI: 10.1155/2022/2209101.

Extracellular Vesicles Derived from Mesenchymal Stromal Cells Delivered during Hypothermic Oxygenated Machine Perfusion Repair Ischemic/Reperfusion Damage of Kidneys from Extended Criteria Donors.

Rampino T, Gregorini M, Germinario G, Pattonieri E, Erasmi F, Grignano M Biology (Basel). 2022; 11(3).

PMID: 35336724 PMC: 8945029. DOI: 10.3390/biology11030350.

Glutaraldehyde-Polymerized Hemoglobin: In Search of Improved Performance as Oxygen Carrier in Hemorrhage Models.

Farcas A, Toma V, Roman I, Sevastre B, Scurtu F, Silaghi-Dumitrescu R Bioinorg Chem Appl. 2020; 2020:1096573.

PMID: 32952540 PMC: 7482000. DOI: 10.1155/2020/1096573.

Biologically active polymer nanosystems.

Panarin E Russ Chem Bull. 2020; 66(10):1812-1820.

PMID: 32214777 PMC: 7088672. DOI: 10.1007/s11172-017-1952-z.

References

Powanda D, Chang T . Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood-brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artif Cells Blood Substit Immobil Biotechnol. 2002; 30(1):23-37. DOI: 10.1081/bio-120002725. View

Perutz M . Stereochemical mechanism of oxygen transport by haemoglobin. Proc R Soc Lond B Biol Sci. 1980; 208(1171):135-62. DOI: 10.1098/rspb.1980.0047. View

DAgnillo F, Chang T . Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol. 1998; 16(7):667-71. DOI: 10.1038/nbt0798-667. View

Chang T . 50th anniversary of artificial cells: their role in biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy and nanorobotics. Artif Cells Blood Substit Immobil Biotechnol. 2007; 35(6):545-54. PMC: 3518485. DOI: 10.1080/10731190701730172. View

Moore E, Moore F, Fabian T, Bernard A, Fulda G, Hoyt D . Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 2009; 208(1):1-13. DOI: 10.1016/j.jamcollsurg.2008.09.023. View

Yu B, Chang T . In vitro and in vivo effects of polyhaemoglobin-tyrosinase on murine B16F10 melanoma. Melanoma Res. 2004; 14(3):197-202. DOI: 10.1097/01.cmr.0000131013.71638.c0. View

Liu Z, Chang T . Effects of PEG-PLA-nano artificial cells containing hemoglobin on kidney function and renal histology in rats. Artif Cells Blood Substit Immobil Biotechnol. 2008; 36(5):421-30. PMC: 3526658. DOI: 10.1080/10731190802369763. View

Yu W, Chang T . Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary report. Artif Cells Blood Substit Immobil Biotechnol. 1994; 22(3):889-93. DOI: 10.3109/10731199409117926. View

Gould S, Moore E, Hoyt D, Ness P, Norris E, Carson J . The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg. 2002; 195(4):445-52; discussion 452-5. DOI: 10.1016/s1072-7515(02)01335-2. View

10.

Yu B, Liu Z, Chang T . Polyhemoglobin with different percentage of tetrameric hemoglobin and effects on vasoactivity and electrocardiogram. Artif Cells Blood Substit Immobil Biotechnol. 2006; 34(2):159-73. DOI: 10.1080/10731190600580223. View

11.

Yu W, Chang T . Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization. Artif Cells Blood Substit Immobil Biotechnol. 1996; 24(3):169-83. DOI: 10.3109/10731199609117433. View

12.

Chang T . Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Commun. 1971; 44(6):1531-6. DOI: 10.1016/s0006-291x(71)80260-7. View

13.

Wong N, Chang T . Polyhemoglobin-fibrinogen: a novel oxygen carrier with platelet-like properties in a hemodiluted setting. Artif Cells Blood Substit Immobil Biotechnol. 2007; 35(5):481-9. DOI: 10.1080/10731190701586210. View

14.

Chang T . Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals. J Bioeng. 1976; 1(1):25-32. View

15.

Liu Z, Chang T . Long-term effects on the histology and function of livers and spleens in rats after 33% toploading of PEG-PLA-nano artificial red blood cells. Artif Cells Blood Substit Immobil Biotechnol. 2008; 36(6):513-24. PMC: 3518481. DOI: 10.1080/10731190802554224. View

16.

Rao S, Jollis J, Harrington R, Granger C, Newby L, Armstrong P . Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004; 292(13):1555-62. DOI: 10.1001/jama.292.13.1555. View

17.

Chang T . SEMIPERMEABLE MICROCAPSULES. Science. 1964; 146(3643):524-5. DOI: 10.1126/science.146.3643.524. View

18.

Chang T, Powanda D, Yu W . Analysis of polyethylene-glycol-polylactide nano-dimension artificial red blood cells in maintaining systemic hemoglobin levels and prevention of methemoglobin formation. Artif Cells Blood Substit Immobil Biotechnol. 2003; 31(3):231-47. DOI: 10.1081/bio-120023155. View

19.

Chang T . Nanobiotechnological modification of hemoglobin and enzymes from this laboratory. Biochim Biophys Acta. 2008; 1784(10):1435-40. PMC: 3514548. DOI: 10.1016/j.bbapap.2008.05.006. View

20.

Chang T . Artificial cells containing multienzyme systems. Methods Enzymol. 1985; 112:195-203. DOI: 10.1016/s0076-6879(85)12017-3. View